FDA OKs Therapy for Deadly Pediatric Immune Disorder

(MedPage Today) — The FDA on Thursday granted accelerated approval to marnetegragene autotemcel (Kresladi) as the first gene therapy for treating kids with severe leukocyte adhesion deficiency type I (LAD-I), an ultra-rare inherited immune deficiency…